These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prognosis of patients with diabetic macular edema before Japanese approval of anti-vascular endothelial growth factor. Serizawa S; Ohkoshi K; Minowa Y; Takahashi O Jpn J Ophthalmol; 2015 Jul; 59(4):244-51. PubMed ID: 26008636 [TBL] [Abstract][Full Text] [Related]
8. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema. Mukkamala L; Bhagat N; Zarbin MA Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069 [TBL] [Abstract][Full Text] [Related]
9. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes. Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953 [TBL] [Abstract][Full Text] [Related]
10. Management of diabetic macular edema in Japan: a review and expert opinion. Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T Jpn J Ophthalmol; 2018 Jan; 62(1):1-23. PubMed ID: 29210010 [TBL] [Abstract][Full Text] [Related]
11. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists. Ogura Y; Shiraga F; Terasaki H; Ohji M; Ishida S; Sakamoto T; Hirakata A; Ishibashi T Jpn J Ophthalmol; 2017 Jan; 61(1):43-50. PubMed ID: 27722786 [TBL] [Abstract][Full Text] [Related]